Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

31-40 of 4090 results

Catalogue Number:

PX-TA1035

Category:

G

Alemtuzumab Biosimilar – Anti-CD52 mAb – Research Grade

Target: CD52
Target Alias Name: Alemtuzumab/Campath-1H/LDP-03/CD52/anti-CD52
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2108

Category:

G

Alextatug Biosimilar – Anti-PABP-1 mAb – Research Grade

Target: PABP-1
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda7
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1105

Category:

G

Alg-991 Biosimilar – Anti-Urushiol mAb – Research Grade

Target: Urushiol
Target Alias Name: Alg-991/ALG-991/Urushiol/anti-Urushiol
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgM-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1287

Category:

G

Alirocumab Biosimilar – Anti-PCSK9 mAb – Research Grade

Target: PCSK9
Target Alias Name: Alirocumab/REGN727/SAR-236553/PCSK9/anti-PCSK9
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1642

Category:

G

Alnuctamab Biosimilar – Anti-TNFRSF17/CD3E mAb – Research Grade

Target: TNFRSF17/CD3E
Target Alias Name: Alnuctamab/ALNUCTAMAB/TNFRSF17/CD3E/anti-TNFRSF17/CD3E
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Bispecific /IgG1/IgG1/Kappa/Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1641

Category:

G

Alomfilimab Biosimilar – Anti-ICOS mAb – Research Grade

Target: ICOS
Target Alias Name: Alomfilimab/IMMUNOGLOBULIN G1/ ANTI-(HUMAN INDUCIBLE COSTIMULATOR PROTEIN) (HUMAN MONOCLONAL KY1044 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL KY1044 .KAPPA.-CHAIN/ DIMER/ KY1044/ KY-1044/ICOS/anti-ICOS
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/ Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1930

Category:

G

alpha/gamma Antibody (Kwar23) Biosimilar – Anti-BIT mAb – Research Grade

Target: BIT
Target Alias Name: anti-BIT/ Signal-regulatory protein alpha-1/ Brain Ig-like molecule with tyrosine-based activation motifs/ MFR/ SIRP/ Sirp-alpha-1/ Sirp-alpha-2/ PTPNS1/ SIRPA/ SHP substrate 1/ CD172 antigen-like family member A/ Sirp-alpha-3/ Inhibitory receptor SHPS-1/ Signal-regulatory protein alpha-3/ CD172a/ Tyrosine-protein phosphatase non-receptor type substrate 1/ MyD-1 antigen/ Bit/ SHPS-1/ Macrophage fusion receptor/ Signal-regulatory protein alpha-2/ SHPS1/ MYD1/ p84/
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 silence
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1807

Category:

G

Alsevalimab Biosimilar – Anti-VTCN1 mAb – Research Grade

Target: VTCN1
Target Alias Name: Alsevalimab//VTCN1/anti-VTCN1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1224

Category:

G

Altumomab Biosimilar – Anti-CEACAM5/ CD66e mAb – Research Grade

Target: CEACAM5/ CD66e
Target Alias Name: Altumomab/ZCE025/CEACAM5/ CD66e/anti-CEACAM5/ CD66e
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1049

Category:

G

Amatuximab Biosimilar – Anti-MSLN mAb – Research Grade

Target: MSLN
Target Alias Name: Amatuximab/MORAb-009/MSLN/anti-MSLN
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression